Abstract
Type 2 diabetes mellitus is caused by the presence of disturbances in insulin secretion, insulin resistance and reduced action of the incretin axis. At present, any disorder can be influenced pharmacologically.
Therefore, combination therapy is a rational basic principle for pharmacological intervention in type 2 diabetes. It facilitates an individual approach to therapy.